SNCA and synucleinopathy: A comprehensive therapeutic approach for synucleinopathies should integrate strategies targeting multiple pathogenic mechanisms, given the complex interplay between α-synuclein aggregation, dopaminergic dysfunction, neuroinflammation, and mitochondrial impairment.